HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies

Author： Lu Su  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.124, Iss.3, 2010-12, pp. : 771-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studies

By Ding Haixia   Fu Yuanyuan   Chen Weixian   Wang Zhanwei  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 265-270

Springer Publishing Company

Access to resources Recommend Favorite

HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case–control analyses

By Millikan Robert  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 309-312

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case–control studies

By Gu Dongying  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 527-531

Springer Publishing Company

Access to resources Recommend Favorite

HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites

By Millikan R.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 355-364

Springer Publishing Company

Access to resources Recommend Favorite

Catechol- O -methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria

By Lajin Bassam  

Breast Cancer, Vol. 20, Iss. 1, 2013-01 ,pp. : 62-66

Springer Publishing Company

Access to resources Recommend Favorite